Thus, novel treatment strategies are indicated for clinical needs, amongst them CD73, an ecto-5′-nucleotidase that has been reported to be associated with a negative survival prognosis of patients, which emerged as an effective approach to combating cancer [92]. The gene discussed is NT5E; the disease is cancer.